Last week, we hosted EmTech MIT, MIT Technology Review’s annual flagship conference in Cambridge, Massachusetts. Over the course of three days of main-stage sessions, I learned about innovations in AI, biotech, and robotics. But as you might imagine, some of this climate reporter’s favorite moments came in the climate sessions. I was listening especially closely…
Alex Blackwood was working as a real estate investing associate at Goldman Sachs. Here’s why he decided to start a business instead — despite the pay cut.
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology. The new company, called Preventive, is being formed to research so-called “heritable genome editing,” in which the DNA of embryos would be…